CXCL10 and type 1 diabetes mellitus: Interestingly, the mean serum CXCL10 level was also found to be elevated in patients at high risk for developing T1D who are carrying antibodies against islet autoantigens indicating that CXCL10 is released during the initial β-cell destructive process (44, 45).